Evaluating the potential of cubosomal nanoparticles for oral delivery of amphotericin B in treating fungal infection

Código QR

Evaluating the potential of cubosomal nanoparticles for oral delivery of amphotericin B in treating fungal infection

Zhiwen Yang,1,3 Meiwan Chen,2 Muhua Yang,1 Jian Chen,1 Weijun Fang,1 Ping Xu11Department of Pharmacy, Songjiang Hospital Affiliated The First People's Hospital, Shanghai Jiao Tong University, Shanghai, 2State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medic...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yang Z, Chen M, Yang M, Chen J, Fang W, Xu P
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/3c3b818ad0c44b7585e6f76f3af76acd
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Cubosome nanoparticles potentiate immune properties of immunostimulants
por: Liu Z, et al.
Publicado: (2016)

Biomimetically engineered Amphotericin B nano-aggregates circumvent toxicity constraints and treat systemic fungal infection in experimental animals
por: Qamar Zia, et al.
Publicado: (2017)

An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasis
por: Ribeiro TG, et al.
Publicado: (2014)

Comparative efficacy of amphotericin B-loaded chitosan nanoparticles and free amphotericin B drug against Leishmania tropica
por: Aamir Sohail, et al.
Publicado: (2021)

Filamentous fungal endophthalmitis: results of combination therapy with intravitreal amphotericin B and voriconazole
por: Mithal K, et al.
Publicado: (2015)

Self-assembled amphotericin B-loaded polyglutamic acid nanoparticles: preparation, characterization and in vitro potential against Candida albicans
por: Zia Q, et al.
Publicado: (2015)

Protective and antifungal properties of Nanodisk-Amphotericin B over commercially available Amphotericin B
por: Do-Yeon Cho, et al.
Publicado: (2017)

Efficacy of intravenous amphotericin B-polybutylcyanoacrylate nanoparticles against cryptococcal meningitis in mice
por: Chen JH, et al.
Publicado: (2011)

Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis
por: R. Lu, et al.
Publicado: (2019)

Self-aggregated nanoparticles based on amphiphilic poly(lactic acid)-grafted-chitosan copolymer for ocular delivery of amphotericin B
por: Zhou WJ, et al.
Publicado: (2013)

Comparison of Amphotericin B Lipid Complex (Abelcet) and Liposomal Amphotericin B (Ambisome) on Rat Kidney: a Morphological Evaluation
por: Mutluay,S. Deniz, et al.
Publicado: (2012)

Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: an effective oral combination against experimental murine visceral leishmaniasis
por: Shabi Parvez, et al.
Publicado: (2020)

Preparation, characterization, and evaluation of amphotericin B-loaded MPEG-PCL-g-PEI micelles for local treatment of oral Candida albicans
por: Zhou L, et al.
Publicado: (2017)

Enhanced antifungal effects of amphotericin B-TPGS-b-(PCL-ran-PGA) nanoparticles in vitro and in vivo
por: Tang X, et al.
Publicado: (2014)

Successful management of Aspergillus infection of an open window thoracostomy with topical liposomal amphotericin B
por: Alexis Legault-Dupuis, et al.
Publicado: (2021)

AT101-Loaded Cubosomes as an Alternative for Improved Glioblastoma Therapy
por: Flak DK, et al.
Publicado: (2020)

Comparison of Safety and Efficacy of Intrastromal Injections of Voriconazole, Amphotericin B and Natamycin in Cases of Recalcitrant Fungal Keratitis: A Randomized Controlled Trial
por: Saluja G, et al.
Publicado: (2021)

Fusion dynamics of cubosome nanocarriers with model cell membranes
por: Brendan P. Dyett, et al.
Publicado: (2019)

Anti-transferrin receptor-modified amphotericin B-loaded PLA–PEG nanoparticles cure Candidal meningitis and reduce drug toxicity
por: Tang X, et al.
Publicado: (2015)

Nanoparticle-mediated drug delivery to treat infections in the female reproductive tract: evaluation of experimental systems and the potential for mathematical modeling
por: Sims LB, et al.
Publicado: (2018)

Probing amphotericin B single channel activity by membrane dipole modifiers.
por: Olga S Ostroumova, et al.
Publicado: (2012)

Design and Characterization of Maltoheptaose-<i>b</i>-Polystyrene Nanoparticles, as a Potential New Nanocarrier for Oral Delivery of Tamoxifen
por: Marcos Antonio Villetti, et al.
Publicado: (2021)

Comparative analysis between four model nanoformulations of amphotericin B-chitosan, amphotericin B-dendrimer, betulinic acid-chitosan and betulinic acid-dendrimer for treatment of Leishmania major: real-time PCR assay plus
por: Zadeh Mehrizi T, et al.
Publicado: (2019)

Acute physiological changes caused by complement activators and amphotericin B-containing liposomes in mice
por: Őrfi E, et al.
Publicado: (2019)

Evaluation of in vitro and in vivo Efficacy of a Novel Amphotericin B-Loaded Nanostructured Lipid Carrier in the Treatment of Leishmania braziliensis Infection
por: Rebouças-Silva J, et al.
Publicado: (2020)

Cubosomes from hierarchical self-assembly of poly(ionic liquid) block copolymers
por: Hongkun He, et al.
Publicado: (2017)

Synthesis, characterization, and mechanistic studies of a gold nanoparticle–amphotericin B covalent conjugate with enhanced antileishmanial efficacy and reduced cytotoxicity
por: Kumar P, et al.
Publicado: (2019)

Brain Targeting of Duloxetine HCL via Intranasal Delivery of Loaded Cubosomal Gel: In vitro Characterization, ex vivo Permeation, and in vivo Biodistribution Studies
por: Elsenosy FM, et al.
Publicado: (2020)

Potential of magnetic nanoparticles for targeted drug delivery
por: Yang HW, et al.
Publicado: (2012)

Case Report: Use of Liposomal Amphotericin B in Low Doses in Patients With Visceral Leishmaniasis
por: Danfeng Ren, et al.
Publicado: (2021)

Radiata Pine Wood Treated with Copper Nanoparticles: Leaching Analysis and Fungal Degradation
por: María Graciela Aguayo, et al.
Publicado: (2021)

Novel piperine-loaded Tween-integrated monoolein cubosomes as brain-targeted oral nanomedicine in Alzheimer’s disease: pharmaceutical, biological, and toxicological studies
por: Elnaggar YSR, et al.
Publicado: (2015)

Physical characterization and in vivo pharmacokinetic study of self-assembling amphotericin B-loaded lecithin-based mixed polymeric micelles
por: Chen YC, et al.
Publicado: (2015)

Cholate-modified polymer-lipid hybrid nanoparticles for oral delivery of quercetin to potentiate the antileukemic effect
por: Yin J, et al.
Publicado: (2019)

Development of an Orally Bioavailable Isoliquiritigenin Self-Nanoemulsifying Drug Delivery System to Effectively Treat Ovalbumin-Induced Asthma
por: Cao M, et al.
Publicado: (2020)

Potential Roles of Fungal Extracellular Vesicles during Infection
por: Luna S. Joffe, et al.
Publicado: (2016)

Capric acid secreted by Saccharomyces boulardii influences the susceptibility of Candida albicans to fluconazole and amphotericin B
por: Jakub Suchodolski, et al.
Publicado: (2021)

In Vitro Pharmacokinetic/Pharmacodynamic Modelling and Simulation of Amphotericin B against <i>Candida auris</i>
por: Unai Caballero, et al.
Publicado: (2021)

A study on the risk of fungal infection with tofacitinib (CP-690550), a novel oral agent for rheumatoid arthritis
por: Yong Chen, et al.
Publicado: (2017)

Nanoparticles from Gantrez-based conjugates for the oral delivery of camptothecin
por: Judit Huarte, et al.
Publicado: (2021)